Photo: Unsplash

Durham-based therapeutics and product research company Lindy Biosciences has secured $1.6 million in Series A funding, according to company database Crunchbase, topping the citys recent funding headlines. The cash infusion was announced Sept. 18 and led by alumshares.

According to its Crunchbase profile, "Lindy is developing high-dose suspension of protein suitable for subcutaneous injection, which will decrease administration costs, increase patient costs, increase patient comfort and compliance, and enable high-dose molecules to reach the market."

The three-year-old startup has raised two previous funding rounds, including a $547,736 seed round earlier this year.

Over the past year, four Durham-based data and analytics companies have secured venture funding, totaling $32 million in new investment to the local industry.

In other local funding news, pharmaceutical company Emergo Therapeutics announced a $500,000 debt financing funding round on Oct. 15, financed by North Carolina Biotechnology Center.

According to Crunchbase, "Emergo is developing treatment options for flu-like illnesses and to boost the bodys immune system response."

The company also raised a $12 million Series A round in 2018.

This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.

Read the original here:
Durham funding news: Data and analytics and biotechnology top recent local investments - Yahoo News